PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: The Scott Partnership

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

GxPi’s x-docs™ Electronic Document Management Solution Achieves Regulatory Compliance for FDAS - FDAS has installed GxPi's x-docs electronic document management system
GxPi’s x-docs™ Electronic Document Management Solution Achieves Regulatory Compliance for FDAS


NewswireToday - /newswire/ - Holmes Chapel, Cheshire, United Kingdom, 2010/07/07 - FDAS has installed GxPi's x-docs electronic document management system.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


GxPi, a leading provider of consulting services and compliance-based products to the pharmaceutical, biopharmaceutical and healthcare industries, today announced that hosted x-docs™, the company’s hosted electronic Document Management Solution (eDMS) solution, has been successfully implemented by Food and Drug Analytical Services Ltd. (FDAS) to manage routine quality control (QC) records for their customers. FDAS is using x-docs™ to store, manage and control vital records, ensuring regulatory compliance and improving laboratory efficiency to improve their customer offering.

FDAS is an independent contract testing laboratory serving the pharmaceutical, biopharmaceutical, veterinary and nutraceuticals sectors and primarily offers routine QC and stability testing throughout the drug manufacturing lifecycle. The company required an eDMS to ensure that all manufacturing and testing processes are thoroughly validated and comply with Good Manufacturing Practice (GMP) and FDA 21 CFR Part 11 regulations. A solution was needed that would keep records created through the drug manufacturing process, building a complete history of each batch of drug product for safety and regulatory purposes. FDAS looked to GxPi to implement an eDMS system that was regulatory-compliant, ensuring quick and easy access to records and offering clients and regulatory authorities a secure and transparent view of all product data.

GxPi’s x-docs™ hosted paperless document management solution is easy to use, ensures regulatory compliance and can be implemented and validated quickly. The system is GMP compliant, enabling FDAS to manage quality documentation, templates and workflows, versions and revisions and create a full audit trail of all GMP documents. The x-docs™ solution also overcomes the costs and complexity of managing traditional server based solutions. Through its consultancy services, GxPi also provides both GMP and IT expertise to FDAS. This unique combination of skills meant that GxPi could provide the FDAS team with an understanding of how the system would operate and the potential benefits before it was selected. GxPi also provided their IT Quality Manager to act as the quality representative for x-docs™ during the organisation’s recent MHRA inspection, answering questions from auditors on behalf of FDAS to guarantee compliance. There were no reported findings on x-docs from the MHRA audit which is a significant success.

Larissa Taylor, Technical Director at FDAS, comments: “As our company communicates with approximately 70 different clients at any one time, it is essential that we have a document management system that is reliable and easy to use. During our investigations of eDMS solutions on the market we found that many systems lacked the rigorous network security and validation procedures required by the pharmaceutical industry. We selected GxPi’s x-docs™ system to improve laboratory efficiency and comply with regulatory and legal requirements in a cost-effective way. The consultancy services offered by the company have added further value, enabling us to achieve efficient compliant processes.”

For more information on GxPi, please call +44 (0) 115 924 8475 or email info[.]

About GxPi
GxPi ( makes regulatory compliance leaner, by providing products and services to the biotechnology, pharmaceutical, consumer healthcare, medical devices and veterinary industries that are “simply compliant”. GxPi’s services arm delivers High Value, High Impact consulting services which cover all aspects of regulatory compliance (GMP, GAMP, GLP, GEP, GCP, GDP), qualified person (QP), quality assurance (QA), validation services (process engineering, computer systems, laboratory equipment), clinical technology, training and project management. GxPi’s solutions arm, provides electronic Document Management solutions (eDMS) to the life sciences sector via the x-docs™ platform. x-docs™ is a new class of document management software which is powerful and practical in enabling organisations to comply with increasing regulatory requirements. x-docs™ is easy to configure, requires little IT support, is cost-effective for organisations of all sizes and are entirely intuitive to use with minimal training.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Written by / Agency / Source: The Scott Partnership


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick Newswire Today Visibility Checker


Distribution / Indexing: [+]

# # #

  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!

GxPi’s x-docs™ Electronic Document Management Solution Achieves Regulatory Compliance for FDAS

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Publisher Contact: Eleanor Thouret - 
+44 1477 539539 gxpi[.]
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Articles From The Scott Partnership / Company Profile

Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy
Greenphire Continues Commitment to Clinical Research Site Sustainability and Innovation at Global Site Solutions Summit
Frost & Sullivan Highlights argenx for Enhancing the Therapeutic Qualities of Human Antibodies with its Proprietary Antibody Discovery Platform, SIMPL
FDA Grants Breakthrough Therapy Designation for Genentech’s Actemra® (Tocilizumab) in Giant Cell Arteritis, a Form of Vasculitis
MDxHealth Announces Agreement with SouthGenetics for Distribution of SelectMDx in Central/South America
BD and Apax Partners Announce Closing of Joint Venture to Launch Global Respiratory Business
Exosome Diagnostics Enters Agreement with Amgen
Sartorius Stedim Biotech Launches Two Single-use Sartocon® Loop Assemblies with Integrated Polyethersulfone (PESU) Membrane
BD Expands Efforts to Combat Antimicrobial Resistance with New Automated ID/AST System

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business


Visit  NAKIVO, Inc.


  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (